Skip to main content
Clinical Trials/CTRI/2019/10/021675
CTRI/2019/10/021675Not yet recruitingNot Applicable

A CROSS SECTIONAL STUDY TO ANALYZE THE RELATION BETWEEN DURATION OF PRAMEHA(DM) AND RENAL DYSFUNCTIONS WITH CYSTATIN-C(SERUM MARKER FINDING)

Parul Institute of Ayurveda1 site in 1 country100 target enrollmentStarted: January 12, 2020Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Enrollment
100
Locations
1
Primary Endpoint
Relation between duration of Prameha and renal dysfunction with Cystatin-C findings.

Study Overview

Brief Summary

In Prameha all thedravadhatus in reference to kapha from shareera gets excreted through mutra.There is a significant change inphysical constitution, chemical contents and biochemical properties in suchmutra. The abnormal metabolic admixture of dustadosha, pradushtadhatu withmutra is nothing but pradusthita mutra or saama mutra. Therefore there is aextra addition of ama and its constituents to mutra which make mutra turnavila.

Normal value of GFR is 125ml/min. A stepwise increase in nitrogenousconstituents of blood like urea, creatinine etc and other biochemicalparameters like albumin, electrolytes etc also believed to reflectdeteriorating kidney function.

Renal involvement is a common complication and a leading cause of deathin diabetes which is classified under late systemic complications.

In chirakaaleena Pramehi dhatu excreted out with mutra can be consideredas samala mutrata or saghana mutrata which signifies the reduced GFR by kidneyslanding up in many renal dysfunctions.Since Cystatin-C is a small protein whichis produced constantly, freely filtered by glomerulus and also fully reabsorbedand broken down by renal tubules is considered as better marker for GFR thanSerum Creatinine.

In this research study the findings of Cystatin-C will help inunderstanding the relation between duration of Prameha vyadhi and Renaldysfunctions occurring in the same which will help in analyzing the involvementof mutravaha srotas.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
30.00 Year(s) to 65.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • •Diagnosed patients of Prameha will be selected with symptoms Prabhoota and Avilamootrata & slight increase in quantity of urine associated with premonitory symptoms and symptoms of DM including Polyurea, Polydipsia, Polyphagia, Lassitude and Weightloss.

Exclusion Criteria

  • •Thyroid dysfunctions, patients with cortico steroids therapy & chronic cigarette smokers Pregnancy with DM Systemic disorders hampering the kidney functions and other major disorders like TB,IHD,HIV associated with DM.

Outcomes

Primary Outcomes

Relation between duration of Prameha and renal dysfunction with Cystatin-C findings.

Time Frame: 1 month

Secondary Outcomes

  • To analyze the involvement of Mutravaha srotas in Prameha by considering Prabhoota and Availa mutra which signifies reduced GFR.(6 month)

Investigators

Sponsor
Parul Institute of Ayurveda
Sponsor Class
Private medical college

Study Sites (1)

Loading locations...

Similar Trials

TO UNDERSTAND THE RELATION BETWEEN... | Clinical Trial